The stock has been rated “underperform.” Analysts from the Jefferies Group have said to “hold” on purchasing the company’s stock, while JPMorgan Chase gave it a “neutral” rating.
Victrex works with manufacturing of high performance polymers through its two business units, Invibio Biomaterial Solutions and Victrex Polymer Solutions.
More Articles on Devices:
MAKO Surgical Settles Lawsuit, Acquires Stanmore Robotic Assets
Stryker Releases Spine Screw, Surgical Devices
Sonoma Orthopedic Products Develops Minimally Invasive Technique For Fractures
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
